Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (413)

« Back to Publications

Sleep Improvement for Metabolic Health: A Feasibility Trial of a Digital Sleep Treatment in People With Insomnia and Non‐Diabetic Hyperglycaemia

Sharman R. et al, (2026), Journal of Sleep Research

A multidimensional framework for mapping social need to electronic health records in people with multimorbidity

Isaac T. et al, (2026), Scientific Reports, 16

Variation in multimorbidity estimates due to clinical coding: a cross-sectional study of 7.2 million adults in England

Isaac T. et al, (2026), BMJ Public Health, 4, e004120 - e004120

Screening for hypertension in the inpatient environment (SHINE): a prospective diagnostic accuracy study among adult hospital patients

Armitage LC. et al, (2026), BMJ Open, 16, e107038 - e107038

The Role of Adaptive and Innovative Trial Designs in Diabetes Research: A Scoping Review.

Goshrani A. et al, (2026), Diabetes care, 49, 197 - 210

Variations in social care need reporting amongst GP practices in England: a retrospective cohort study in people with multimorbidity.

Burns D. et al, (2025), BMC primary care, 26

Potential cost-effectiveness of childhood screening for type 1 diabetes: Examining reducing Diabetic Ketoacidosis at diagnosis and long-term outcomes to assess the justifiable cost per child screened.

Pollard DJ. et al, (2025), NIHR Open Research, 5, 80 - 80

Once weekly insulin in type 2 diabetes.

Farmer A. et al, (2025), BMJ (Clinical research ed.), 390

SPIRIT 2025 Statement

Chan A-W. et al, (2025), JAMA, 334, 435 - 435

Evaluating prediction of short-term tolerability of five type 2 diabetes drug classes using routine clinical features: UK population-based study.

Cardoso P. et al, (2025), Diabetes, obesity & metabolism, 27, 4320 - 4329

CONSORT 2025 statement: updated guideline for reporting randomized trials: a Korean translation

Hopewell S. et al, (2025), Ewha Medical Journal, 48, e50 - e50

CONSORT 2025 Statement

Hopewell S. et al, (2025), JAMA, 333, 1998 - 1998

Experiences of Using a Digital Text Messaging Intervention to Support Oral Medication Adherence for People Living With Type 2 Diabetes: Qualitative Process Evaluation

Newhouse N. et al, (2025), Journal of Medical Internet Research, 27, e70203 - e70203

SPIRIT 2025 statement: updated guideline for protocols of randomized trials

Chan A-W. et al, (2025), Nature Medicine, 31, 1784 - 1792

Reducing inequalities through greater diversity in clinical trials – As important for medical devices as for drugs and therapeutics

Roope LSJ. et al, (2025), Contemporary Clinical Trials Communications, 45, 101467 - 101467

Load More

1
2
3
4
5
6
7
...
»